LogicBio Therapeutics Inc (NASDAQ:LOGC)

9.45
Delayed Data
As of 3:59pm ET
 +2.02 / +27.19%
Today’s Change
3.05
Today|||52-Week Range
11.60
+31.25%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for LogicBio Therapeutics Inc have a median target of 22.00, with a high estimate of 24.00 and a low estimate of 20.00. The median estimate represents a +132.80% increase from the last price of 9.45.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in LogicBio Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$0.00
Reporting Date
Dec 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -17.86%
 
 
 
 
 
 
Growthannually 7.72%
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually --
Key to the earnings and sales forecast charts.